Antibody & TIDES Summit 2025
Jean Ge will speak on two panels at the Antibody & TIDES Summit 2025.
Navigating Regulatory Challenges in Oligonucleotide Therapeutics and Associated IP Considerations
September 9, 2025 l 11:30am-12:20pm
Panelists:
- Jean Ge | Patent Attorney, Wolf Greenfield
- Maria Liljevald | Head of Global Regulatory Affairs, Ribocure Pharmaceuticals AB
- Sonja Merkas | Founder, Livinovea
Peptide vs. Oligo: Which Modality Wins in the Next 10 Years?
September 10, 2025 l 9:00-9:50am
Panelists:
- Jean Ge | Patent Attorney, Wolf Greenfield
- Dr David Gilot | Director, AstraZeneca
- Dr Piotr Putaj | Director Oligonucleotide Chemistry, Vico Therapeutics
- Troels Koch | Chief Technology Officer, MiNA Therapeutics